<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02378857</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1331 (REK)</org_study_id>
    <secondary_id>2014077</secondary_id>
    <nct_id>NCT02378857</nct_id>
  </id_info>
  <brief_title>Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term Effects</brief_title>
  <official_title>Fontan Circulation and Cardiopulmonary Function: Prognostic Factors, Hemodynamics and Long-term Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cross-sectional study of a national cohort of adolescents with univentricular congenital
      heart defects and Fontan type palliation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A study group of 40-50 individuals will be investigated by non-invasive and invasive methods,
      including echocardiography at rest and during exercise, heart catheterization with advanced
      hemodynamic studies, cardiac and abdominal MRI, abdominal ultrasound and transient
      elastography, quality of life assessment and cardiopulmonary exercise testing. A selection of
      tests will be performed in a healthy control group as well.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hemodynamic status</measure>
    <time_frame>Current at time of inclusion</time_frame>
    <description>Status as found by invasive and non-invasive assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Structural and functional hepatic changes</measure>
    <time_frame>Current at time of inclusion</time_frame>
    <description>Status as found by non-invasive assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardio-pulmonary function and functional reserve</measure>
    <time_frame>Current at time of inclusion</time_frame>
    <description>Status as found by non-invasive assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life and psycho-social outcome</measure>
    <time_frame>Current at time of inclusion</time_frame>
    <description>Status as found by questionnaire</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Patient group</arm_group_label>
    <description>Adolescents (15-18 years of age) With univentricular heart defects and Fontan type palliation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Age- and gender-matched healthy individuals</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EDTA, citrate and serum samples for analysis for vitamin status, biochemical analysis,
      inflammation markers and organ specific markers.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adolescents i Norway with univentricular heart defects and Fontan type palliation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age, heart defect, heart surgery and type of palliation/correction, informed consent

        Exclusion Criteria:

          -  non-consenting, contraindications or increased risk to perform study tests (i.e. metal
             parts prohibiting MRI, motoric impairment prohibiting CPET)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik Thaulow, professor</last_name>
    <role>Study Director</role>
    <affiliation>Oslo University Hospital, University of Oslo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Moller, MD PhD</last_name>
    <phone>+4790149702</phone>
    <email>thomas.moller@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erik Thaulow, MD PhD</last_name>
    <phone>+4797177901</phone>
    <email>ethaulow@ous-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital, Rikshospitalet, Department of Paediatric Cardiology</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Moller, MD PhD</last_name>
      <phone>+4790149702</phone>
      <email>thomas.moller@ous-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Erik Thaulow, MD PhD</last_name>
      <phone>+4797177901</phone>
      <email>ethaulow@ous-hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>February 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2015</study_first_posted>
  <last_update_submitted>April 18, 2017</last_update_submitted>
  <last_update_submitted_qc>April 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Thomas MÃ¶ller</investigator_full_name>
    <investigator_title>Senior consultant pediatric cardiologist, MD PhD</investigator_title>
  </responsible_party>
  <keyword>Univentricular heart defect</keyword>
  <keyword>Fontan circulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

